The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Innovia Medical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Innovia Medical designs, develops and manufactures specialty surgical and sterile processing essentials. It is a global manufacturer of branded single-use surgical products and sterile processing systems for ophthalmic, gynecological, aesthetic and ENT markets. Its product portfolio includes aesthetic and reconstructive, ear, nose, and throat, ophthalmology, single-use instruments, and sterile processing. the company also offers aspirator accessories, cannula accessories, rhinoplasty, nasal splints, ventilation tubes, and nasal packing among others. The company offers its products globally. Innovia Medical is headquartered in St. Paul, Minnesota, the US. Key subsidiaries of Innovia Medical include Eagle Labs, Medical Device Resource, Network Medical Products, DTR Medical and Lacrimedics.
The key metrics of Innovia Medical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Innovia Medical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Innovia Medical.
For a detailed understanding of the performance of Innovia Medical, buy the report here.